Evidence map›Paper›PMID 32273351›Full record

ArticleMicrobiology resource announcements2020

Draft Whole-Genome Sequences of Ciprofloxacin-Resistant Derivatives of a Bacillus anthracis ΔANR Strain Lacking pXO1 and pXO2 Plasmids.

Tracey D Biggs, Mark A Karavis, Jacquelyn V Harris, Jessica M Hill, Robert C Bernhards, Lance B Price, Paul Keim, Bruce G Goodwin, Shanmuga Sozhamannan

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology resource announcements, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Tracey D BiggsUS Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
Mark A KaravisUS Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
Jacquelyn V HarrisUS Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
Jessica M HillUS Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
Robert C BernhardsUS Army Combat Capabilities Development Command, Chemical Biological Center, Aberdeen Proving Ground, Aberdeen, Maryland, USA.
Lance B PriceDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.
Paul KeimThe Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, Arizona, USA.ORCID https://orcid.org/0000-0003-0089-5820
Bruce G GoodwinDefense Biological Product Assurance Office, CBRND-EB, JPEO, Frederick, Maryland, USA.
Shanmuga SozhamannanDefense Biological Product Assurance Office, CBRND-EB, JPEO, Frederick, Maryland, USA shanmuga.sozhamannan.ctr@mail.mil.
United States Army Combat Capabilities Development Command · USDefense Threat Reduction Agency · USLogistics Management Institute (United States) · USMilken Institute · USNorthern Arizona University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutants of an attenuated

Identifiers

PMID32273351
PMCPMC7380533
OpenAlexW3015248754

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.